Gland Pharma Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 45.75% of Gland Pharma, FIIs hold 10.36%, DIIs hold 33.21% and the public holds 10.68%. Promoter holding fell by 6.02 percentage points from Jun 2026.
Get an alert when Gland Pharma reports results or its shareholding changes. Free account.
Promoters
45.75%
−6.02 pp QoQ
FIIs
10.36%
+1.62 pp QoQ
DIIs
33.21%
+2.77 pp QoQ
Public
10.68%
+1.62 pp QoQ
Gland Pharma shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Government | Public | Shareholders |
|---|---|---|---|---|---|---|
| Sep 2026 | 45.75% | 10.36% | 33.21% | 0.01% | 10.68% | 1,25,667 |
| Jun 2026 | 51.77% | 8.74% | 30.44% | 0.00% | 9.06% | 1,08,266 |
| Mar 2026 | 51.83% | 7.29% | 33.36% | 0.00% | 7.52% | 91,500 |
| Dec 2025 | 51.83% | 7.58% | 32.99% | 0.00% | 7.62% | 94,578 |
| Sep 2025 | 51.83% | 7.90% | 32.63% | 0.00% | 7.63% | 97,151 |
| Jun 2025 | 51.83% | 7.39% | 32.86% | 0.00% | 7.93% | 1,10,671 |
| Mar 2025 | 51.83% | 6.90% | 33.27% | 0.00% | 8.00% | 1,13,788 |
| Dec 2024 | 51.83% | 5.04% | 34.80% | 0.00% | 8.33% | 1,21,075 |
| Sep 2024 | 51.83% | 4.48% | 35.37% | 0.00% | 8.33% | 1,22,358 |
| Jun 2024 | 51.83% | 6.88% | 32.83% | 0.00% | 8.46% | 1,22,665 |
| Mar 2024 | 57.86% | 3.59% | 25.23% | 0.00% | 13.32% | 1,22,375 |
| Dec 2023 | 57.86% | 4.05% | 24.17% | 0.00% | 13.93% | 1,36,021 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Government · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹55.01k cr, the promoter group's 45.75% stake is worth ₹25.17k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Gland Pharma shareholding: common questions
What is the promoter holding in Gland Pharma?
Promoters hold 45.75% of Gland Pharma as of Sep 2026. Their stake fell by 6.02 percentage points from Jun 2026.
How much do FIIs hold in Gland Pharma?
Foreign institutional investors (FIIs) held 10.36% of Gland Pharma in Sep 2026, +1.62 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Gland Pharma?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 33.21% of Gland Pharma in Sep 2026, +2.77 pp versus Jun 2026.
Is the promoter holding in Gland Pharma pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Gland Pharma.
How has Gland Pharma's promoter holding changed in the last year?
Promoter holding moved from 51.83% in Sep 2025 to 45.75% in Sep 2026 (−6.08 pp).
How many shareholders does Gland Pharma have?
Gland Pharma had 1,25,667 shareholders in Sep 2026, compared with 1,08,266 in Jun 2026.